COMMUNIQUÉS West-GlobeNewswire

Daré Bioscience, Inc. To Participate in the LD Micro Virtual Conference
27/02/2018
SAN DIEGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, today announced that Sabrina Martucci Johnson, President and Chief Executive [...]
Zogenix to Release Fourth Quarter and Full-Year 2017 Financial Results and Host Conference Call and Webcast on March 6
27/02/2018
EMERYVILLE, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]
Excellent Cohort A Data From Final Primary Evaluation Period in Cynata GvHD Phase 1 Clinical Trial
27/02/2018
MELBOURNE, Australia, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP) is pleased to announce that the Primary Evaluation Period has been [...]
PhaseBio Awarded $2.8 Million NIH SBIR Grant to Support Clinical Development of PB1046 in Pulmonary Arterial Hypertension
27/02/2018
MALVERN, Pa., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced that the Company has [...]
Healthwise Launches its FHIR® App in Epic’s App Orchard to Improve Integration of High-Quality, Evidence-Based Patient Education
27/02/2018
BOISE, Idaho, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Striving to improve health care quality and outcomes by making it easier to get patients the information they need to better manage their health, Healthwise announced [...]
Tetraphase Pharmaceuticals Announces FDA Acceptance for Filing of its NDA Submission for Eravacycline for the Treatment of Complicated Intra-Abdominal Infections (cIAI)
27/02/2018
WATERTOWN, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
HempAmericana Announces High-Capacity CBD Oil Extraction Equipment Arrives On-Site; Fully-Owned Machine has Potential to Catapult Company Into Top-Tier Position
27/02/2018
NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce the arrival of its new Vitalis R-200 high-capacity supercritical CO2 [...]
Maple Leaf Announces Conditional Approval for Transfer Listing of Common Shares to the Aequitas NEO Exchange Inc.
27/02/2018
CALGARY, Alberta, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (TSX-V: MGW ) (OTCQB:MGWFF) announces that, further to the Company’s press release dated February 6, [...]
BioCryst Pharmaceuticals and Idera Pharmaceuticals File Preliminary Proxy Statement and Investor Presentation in Connection with Pending Merger
27/02/2018
Provide Update on Key Benefits of Pending Merger and Comprehensive Evaluation of Strategic Opportunities Leading Up to Definitive Merger Agreement BioCryst and Idera Boards of Directors Unanimously Recommend Respective [...]
Vital Therapies Announces Upcoming Fourth Quarter and Full Year Financial Results Conference Call with Webcast and Participation in Upcoming Conference
27/02/2018
SAN DIEGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release [...]
ICC Labs Receives Two Additional Medicinal Cannabis Licenses in Colombia
27/02/2018
Highlights: The Ministry of Justice and Law of the Republic of Colombia granted ICC Labs a license for the cultivation of psychoactive (high-THC) cannabis plants. The Ministry of Health of the Republic of Colombia [...]
XORTX Therapeutics Provides Corporate Update
27/02/2018
CALGARY, Alberta, Feb. 27, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney [...]
Actinium Pharmaceuticals Announces Activation of Sixteenth Clinical Trial Site in the Pivotal Phase 3 SIERRA Trial for Iomab-B
27/02/2018
- Current clinical trial sites represent over one-third of bone marrow transplant volume in the U.S. - Actinium expects continued site additions to support enrollment and trial completion objectives NEW YORK, Feb. 27, [...]
Alimera Sciences to Present at the 38th Annual Cowen & Co. Health Care Conference
27/02/2018
ATLANTA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM ) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that Dan Myers, [...]
Cutera to Present at Two Upcoming Healthcare Conferences
27/02/2018
BRISBANE, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq: CUTR ), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that James Reinstein, [...]
Misonix to Present at the 13th Annual Canaccord Genuity Musculoskeletal Conference on March 6
27/02/2018
FARMINGDALE, N.Y., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON ) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Arch Biopartners Announces Start of GMP Manufacturing for Metablok at CSBio
27/02/2018
TORONTO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners, Inc., (Arch or the Company) (TSX-V: ARCH ) (OTCBB: ACHFF ) a portfolio-based biotechnology company, today announced CSBio of Menlo Park, California, has [...]
AxoGen Named Employee Engagement Best Practices Award Winner by DecisionWise International
27/02/2018
ALACHUA, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced it has received a 2018 [...]
ADMA Biologics to Present at Raymond James’ 39th Annual Institutional Investors Conference
27/02/2018
RAMSEY, N.J. and BOCA RATON, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA ) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company that develops, [...]

Pages